AMGN May 2024 215.000 put
| Previous close | 0.0700 |
| Open | 0.0700 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 215.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.0700 - 0.0700 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Yahoo Finance Video
Amgen, DraftKings, Live Nation: Trending tickers
Shares of Amgen (AMGN) are soaring at Thursday's market close after reporting first quarter results, with revenue exceeding expectations. The biotechnology giant's revenue rose by 22% during the quarter. DraftKings (DKNG) also delivered a strong earnings report, surpassing analysts' estimates on both the top and bottom lines. Buoyed by this performance, the company raised its full-year outlook. Live Nation (LYV) topped revenue estimates in its first quarter earnings, although the company reported a loss of $0.53 per share. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Angel Smith
- GuruFocus.com
Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
Amgen reports a 22% revenue increase and significant progress in rare disease treatments and pipeline development.
Investor's Business DailyAmgen Is 'Very Encouraged' With Its Obesity Study; Shares Rocket 13%
Amgen stock popped late Thursday despite its profit beat as investors watch its potential rivals to Lilly and Novo drugs.
